Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma

Vander, 1968, The significance of non-toxic nodules: final report of a 15 year study of the incidence of thyroid malignancy, Ann Intern Med, 69, 537, 10.7326/0003-4819-69-3-537 Mazzaferri, 1992, Thyroid cancer in thyroid nodules: finding a needle in the haystack, Am J Med, 93, 359, 10.1016/0002-9343(92)90163-6 Mittendorf, 1999, Follow-up evaluation and clinical course of patients with benign nodular thyroid disease, Am Surg, 65, 653, 10.1177/000313489906500710 Rosai, 1992, Tumors of the thyroid gland Grieco, 1990, PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas, Cell, 60, 557, 10.1016/0092-8674(90)90659-3 Santoro, 1993, Involvement of RET oncogene in human tumors: specificity of RET activation to thyroid tumors, Br J Cancer, 68, 460, 10.1038/bjc.1993.370 Santoro, 1994, Molecular characterization of RET/PTC3: a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma, Oncogene, 9, 509 Mutter, 1995, A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers, Am J Pathol, 146, 501 Santoro, 1995, Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B, Science, 267, 381, 10.1126/science.7824936 Melillo, 2001, Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade, Mol Cell Biol, 21, 4177, 10.1128/MCB.21.13.4177-4187.2001 Basolo, 2002, Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma, Am J Pathol, 160, 247, 10.1016/S0002-9440(10)64368-4 Santoro, 1990, The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas, Oncogene, 5, 1595 Tallini, 1998, RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes, Clin Cancer Res, 4, 287 Viglietto, 1995, RET/PTC oncogene activation is an early event in thyroid carcinogenesis, Oncogene, 11, 1207 Izzo, 1987, A new human species of aldolase A mRNA from fibroblasts, Eur J Biochem, 164, 9, 10.1111/j.1432-1033.1987.tb10984.x Basolo, 1999, Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell line by insertion of the bcl-2 gene, Int J Cancer, 81, 956, 10.1002/(SICI)1097-0215(19990611)81:6<956::AID-IJC19>3.0.CO;2-N Hui, 2000, Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome, Lab Invest, 80, 965, 10.1038/labinvest.3780099 Albores-Saavedra, 1991, The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases, Hum Pathol, 22, 1195, 10.1016/0046-8177(91)90101-T Mai, 2001, Ret oncogene protein expression in papillary thyroid carcinoma and related lesions, Tumori, 87, 166, 10.1177/030089160108700311 Sugg, 1998, Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia, J Clin Endocrinol Metab, 83, 4116 Bunone, 2000, RET receptor expression in thyroid follicular epithelial cell-derived tumors, Cancer Res, 60, 2845 Fluge, 2001, Expression and alternative splicing of c-RET RNA in papillary thyroid carcinomas, Oncogene, 20, 885, 10.1038/sj.onc.1204161 Cinti, 2000, RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH, Cytogenet Cell Genet, 88, 56, 10.1159/000015485 Apel, 1995, Clonality of thyroid nodules in sporadic goiter, Diagn Mol Pathol, 4, 113, 10.1097/00019606-199506000-00007 Ferrer-Roca, 1998, Genetic heterogeneity of benign thyroid lesions. Static and flow cytometry, karyotyping and in situ hybridization analysis, Anal Cell Pathol, 16, 101, 10.1155/1998/275452 1997, 59 Limpens, 1991, Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia, Oncogene, 6, 2271 Williams, 2000, Guest editorial: two proposals regarding the terminology of thyroid tumors, Int J Surg Pathol, 8, 181, 10.1177/106689690000800304 Ishizaka, 1991, Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method, Oncogene, 6, 1667 Bounacer, 1997, High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation, Oncogene, 15, 1263, 10.1038/sj.onc.1200206 Elisei, 2001, Ret/ptc rearrangements in thyroid nodules: studies in irradiated, malignant and benign thyroid lesions in children and adults, J Clin Endocrinol Metab, 86, 3211 Mizuno, 1997, Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis, Oncogene, 15, 1455, 10.1038/sj.onc.1201313 Rabes, 2000, Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications, Clin Cancer Res, 6, 1093 Nikiforova, 2000, Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells, Science, 290, 138, 10.1126/science.290.5489.138 Nikiforov, 1996, Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis, J Clin Endocrinol Metab, 81, 9 Moniz, 2002, Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation, Eur J Endocrinol, 146, 27, 10.1530/eje.0.1460027 Huang, 2001, Gene expression in papillary thyroid carcinoma reveals highly consistent profiles, Proc Natl Acad Sci USA, 98, 15044, 10.1073/pnas.251547398